EBI said it has acquired Xstim, a division of Precision Medical Products, focused on developing next-generation bone growth stimulation solutions.
EBI is a portfolio company of Avista Healthcare Partners, a middle-market healthcare private equity firm.
The acquisition of Xstim expands EBI's bone growth stimulation portfolio with a wearable, non-invasive spine fusion stimulation therapy designed to support patient comfort, ease of use and clinical confidence. By adding Xstim's capacitively coupled electrical stimulation technology to EBI's platform of non-surgical and implantable bone healing solutions, EBI is positioned to offer surgeons, patients, and care teams a broader range of clinically supported options across lumbar spinal fusion, nonunion fracture, and failed joint fusion applications.
"Our vision is clear: to be the trusted market leader in bone growth stimulation, dedicated to partnering with physicians to improve their patients' bone healing outcomes. The addition of Xstim further supports our mission by introducing next generation products, strengthening our portfolio and expanding our R&D pipeline focused on today's modern needs for both surgeons and patients," said EBI CEO Kevin Kenny in a statement.
In 2024, Xstim received FDA premarket approval for its spinal fusion therapy device.
